|
General Information
|
|
|
Product
|
Chimaerin beta 2 Peptide
|
|
Description
|
Antigenic Blocking Peptide Beta-chimaerin
|
|
Verified Applications
|
Immunocompetition, Immunodepletion
|
|
Peptide Description
|
Synthetic peptide taken within amino acid region 150-180 on beta 2-chimaerin protein.
|
|
Accession #
|
NCBI: NM_004067
|
|
Physical Properties
|
|
|
Quantity
|
250 µg
|
|
Volume
|
100 µl
|
|
Form
|
Antigenic Blocking Peptide
|
|
Storage
|
-20⁰C for long term storage
|
|
Application Protocol
|
|
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
|
Protein
|
|
|
Uniprot #
|
P52757
|
|
Overview
|
GTPase-activating protein for p21-rac. May play role in progression from low-grade to high-grade tumors.
|
|
Molecular Function
|
Metal binding; Zinc
|
|
Subcellular Location
|
Membrane
|
|
Expression
|
Brain, pancreas, heart, placenta. Weakly expressed in kidney and liver.
|
|
Structure
|
Contains 1 phorbol-ester/DAG-type zinc finger; 1 Rho-GAP domain; 1 SH2 domain.
|
|
Alternative Nomenclature
|
ARHGAP3 antibody
BCH antibody
CHN2 antibody
MGC138360 antibody
Rho GTPase activating protein 3 antibody
RHOGAP3 antibody
|
Chimaerin beta 2 Antibody
Chimaerin beta 2 Antibody FITC
Chimaerin beta 2 Antibody BIOTIN
Chimaerin beta 2 Positive Control
